Patent · US Active

S1P and/or ATX modulating agents

US9771326B2 · kind B2 · utility

5Cited by

2References

11Claims

0Family size

Assignee

Biogen MA Inc. · US

Inventors

Hairuo Peng · Needham, US
Zhili Xin · Lake Bluff, US
Lihong Sun · Lexington, US
Timothy Chan · Cambridge, US
Gnanasambandam Kumaravel · Westford, US
Arthur G. Taveras · Rockaway, US

Key dates

Filing date	Nov 20, 2013
Grant date	Sep 26, 2017
Priority date	—
Expiry date	Nov 20, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2602/44
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula (I), and pharmaceutically acceptable salts thereof, can modulate the activity of one or more SIP receptors and/or the activity of autotaxin (ATX).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.